US 8445507
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
granted A61KA61K31/4439A61K9/48
Quick answer
US patent 8445507 (Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases) held by The Regents of the University of California expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/4439, A61K9/48, A61P, A61P13/08